AffloVest

AffloVest is the lightest, first truly portable High Frequency Chest Wall Oscillation (HFCWO) vest, now available in the U.S. Approved for Medicare and private health insurance reimbursement, AffloVest provides treatment of respiratory diseases like Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Chronic Bronchitis, and similar related ailments.Unlike other HFCWO vests, the AffloVest features built-in oscillating compressor modules that allow for freedom of movement to travel, go for a walk in the park, move around the house, or relax in front of the television.The AffloVest is a physician prescribed oscillation treatment device. Respiratory patients should consult their physician to determine how AffloVest can help.


Benefits:

Freedom of Movement

Lightweight and non-restrictive, the AffloVest leaves the user fully mobile during treatments. Users can go for a walk in the park, move around the house, or relax in front of the television.Postural independence; because of the unique integral module system, the treatment does not vary with the patient’s position, unlike other HFCWOs on the market. Treatments can be administered while sitting, standing, or laying down. (This is a great feature for patients with ALS or Muscular Dystrophy.)Rechargeable battery pack with several hours of lifeWeighs only ten pounds, making it the lightest oscillation vest on the marketEasy to store and easy to carry; perfect for the respiratory patient who travelsAvailable in 5 sizes (XS, S, M, L, XL).

Ease of Use

The AffloVest puts complete control of treatments in the patient’s hands.Nine total setting variations let patients choose their own level of treatmentThree modes of oscillation treatment (Drainage, Vibration, Percussion)Three adjustable intensity levels (Soft, Medium, Intense)Quiet during operationAC/DC power option allows users to recharge the vest at home or in the carJust What the Doctor OrderedDoctors recommend HFCWO vests for their effectiveness in providing airway clearance.  German-engineered and already widely adopted in Europe, the AffloVest is now available in the U.S. market to those with a doctor’s prescription, and is approved for Medicare and private health insurance reimbursement.